Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 187 entries
Sorted by: Best Match Show Resources per page
Correction to: Polarisation vision: overcoming challenges of working with a property of light we barely see.

Die Naturwissenschaften

Foster JJ, Temple SE, How MJ, Daly IM, Sharkey CR, Wilby D, Roberts NW.
PMID: 29744587
Naturwissenschaften. 2018 May 03;105(5):32. doi: 10.1007/s00114-018-1559-8.

In "Polarisation vision: overcoming challenges of working with a property of light we barely see" (Foster et al. 2018) we provide a basic description of how Stokes parameters can be estimated and used to calculate the angle of polarisation...

Cite
Foster JJ, Temple SE, How MJ, et al. Correction to: Polarisation vision: overcoming challenges of working with a property of light we barely see. Naturwissenschaften. 2018;105(5):32doi: 10.1007/s00114-018-1559-8.
Foster, J. J., Temple, S. E., How, M. J., Daly, I. M., Sharkey, C. R., Wilby, D., & Roberts, N. W. (2018). Correction to: Polarisation vision: overcoming challenges of working with a property of light we barely see. Die Naturwissenschaften, 105(5), 32. https://doi.org/10.1007/s00114-018-1559-8
Foster, James J, et al. "Correction to: Polarisation vision: overcoming challenges of working with a property of light we barely see." Die Naturwissenschaften vol. 105,5 (2018): 32. doi: https://doi.org/10.1007/s00114-018-1559-8
Foster JJ, Temple SE, How MJ, Daly IM, Sharkey CR, Wilby D, Roberts NW. Correction to: Polarisation vision: overcoming challenges of working with a property of light we barely see. Naturwissenschaften. 2018 May 03;105(5):32. doi: 10.1007/s00114-018-1559-8. PMID: 29744587; PMCID: PMC6828073.
Copy Download .nbib Format: NLM
Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?.

Annals of hepato-biliary-pancreatic surgery

Tan CHN, Yu Y, Tan YRN, Lim BLK, Iyer SG, Madhavan K, Kow AWC, Mayworm AM, Sharkey JD.
PMID: 29536053
Ann Hepatobiliary Pancreat Surg. 2018 Feb;22(1):27-35. doi: 10.14701/ahbps.2018.22.1.27. Epub 2018 Feb 26.

BACKGROUNDS/AIMS: Liver Transplantation (LT) is a recognized treatment for Hepatocellular Carcinoma (HCC). The role of Bridging Therapies (BT) remains controversial.METHODS: From January 2001 to October 2012, 192 patients were referred to the National University Hospital, Singapore for consideration of...

Cite
Tan CHN, Yu Y, Tan YRN, et al. Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?. Ann Hepatobiliary Pancreat Surg. 2018;22(1):27-35doi: 10.14701/ahbps.2018.22.1.27.
Tan, C. H. N., Yu, Y., Tan, Y. R. N., Lim, B. L. K., Iyer, S. G., Madhavan, K., Kow, A. W. C., Mayworm, A. M., & Sharkey, J. D. (2018). Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?. Annals of hepato-biliary-pancreatic surgery, 22(1), 27-35. https://doi.org/10.14701/ahbps.2018.22.1.27
Tan, Chun Han Nigel, et al. "Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?." Annals of hepato-biliary-pancreatic surgery vol. 22,1 (2018): 27-35. doi: https://doi.org/10.14701/ahbps.2018.22.1.27
Tan CHN, Yu Y, Tan YRN, Lim BLK, Iyer SG, Madhavan K, Kow AWC, Mayworm AM, Sharkey JD. Bridging therapies to liver transplantation for hepatocellular carcinoma: A bridge to nowhere?. Ann Hepatobiliary Pancreat Surg. 2018 Feb;22(1):27-35. doi: 10.14701/ahbps.2018.22.1.27. Epub 2018 Feb 26. PMID: 29536053; PMCID: PMC5845608.
Copy Download .nbib Format: NLM
Targeting the gut to treat obesity and its metabolic consequences: view from the Chair.

International journal of obesity supplements

Sharkey KA.
PMID: 28685022
Int J Obes Suppl. 2016 Dec;6:S3-S5. doi: 10.1038/ijosup.2016.2. Epub 2016 Nov 16.

The neurohumoral signaling systems of the gastrointestinal (GI) tract are considered the most significant of the peripheral inputs controlling both food intake in the short term and energy balance over a longer time course. The importance of the GI...

Cite
Sharkey KA. Targeting the gut to treat obesity and its metabolic consequences: view from the Chair. Int J Obes Suppl. 2016;6:S3-S5doi: 10.1038/ijosup.2016.2.
Sharkey, K. A. (2016). Targeting the gut to treat obesity and its metabolic consequences: view from the Chair. International journal of obesity supplements, 6S3-S5. https://doi.org/10.1038/ijosup.2016.2
Sharkey, K A. "Targeting the gut to treat obesity and its metabolic consequences: view from the Chair." International journal of obesity supplements vol. 6 (2016): S3-S5. doi: https://doi.org/10.1038/ijosup.2016.2
Sharkey KA. Targeting the gut to treat obesity and its metabolic consequences: view from the Chair. Int J Obes Suppl. 2016 Dec;6:S3-S5. doi: 10.1038/ijosup.2016.2. Epub 2016 Nov 16. PMID: 28685022; PMCID: PMC5485877.
Copy Download .nbib Format: NLM
A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein.

Current drug discovery technologies

Sharker SM, Rahman A.
PMID: 32164511
Curr Drug Discov Technol. 2021;18(3):354-364. doi: 10.2174/1570163817666200312102137.

Most of the clinical approved protein-based drugs or under clinical trials have a profound impact on the treatment of critical diseases. The mammalian eukaryotic cells culture approaches, particularly the CHO (Chinese Hamster Ovary) cells are mainly used in the...

Cite
Sharker SM, Rahman A. A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein. Curr Drug Discov Technol. 2021;18(3):354-364doi: 10.2174/1570163817666200312102137.
Sharker, S. M., & Rahman, A. (2021). A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein. Current drug discovery technologies, 18(3), 354-364. https://doi.org/10.2174/1570163817666200312102137
Sharker, Shazid Md, and Rahman, Atiqur. "A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein." Current drug discovery technologies vol. 18,3 (2021): 354-364. doi: https://doi.org/10.2174/1570163817666200312102137
Sharker SM, Rahman A. A Review on the Current Methods of Chinese Hamster Ovary (CHO) Cells Cultivation for the Production of Therapeutic Protein. Curr Drug Discov Technol. 2021;18(3):354-364. doi: 10.2174/1570163817666200312102137. PMID: 32164511.
Copy Download .nbib Format: NLM
Target delivery of β-cyclodextrin/paclitaxel complexed fluorescent carbon nanoparticles: externally NIR light and internally pH sensitive-mediated release of paclitaxel with bio-imaging.

Journal of materials chemistry. B

Sharker SM, Kim SM, Kim SH, In I, Lee H, Park SY.
PMID: 32262580
J Mater Chem B. 2015 Jul 28;3(28):5833-5841. doi: 10.1039/c5tb00779h. Epub 2015 Jun 22.

The development of cooperative drug delivery systems that can detect and target the disease site, with rapid trigger controlled drug release (internally and externally), is widely expected to change the landscape of future drug carriers. In this study a...

Cite
Sharker SM, Kim SM, Kim SH, et al. Target delivery of β-cyclodextrin/paclitaxel complexed fluorescent carbon nanoparticles: externally NIR light and internally pH sensitive-mediated release of paclitaxel with bio-imaging. J Mater Chem B. 2015;3(28):5833-5841doi: 10.1039/c5tb00779h.
Sharker, S. M., Kim, S. M., Kim, S. H., In, I., Lee, H., & Park, S. Y. (2015). Target delivery of β-cyclodextrin/paclitaxel complexed fluorescent carbon nanoparticles: externally NIR light and internally pH sensitive-mediated release of paclitaxel with bio-imaging. Journal of materials chemistry. B, 3(28), 5833-5841. https://doi.org/10.1039/c5tb00779h
Sharker, Shazid Md, et al. "Target delivery of β-cyclodextrin/paclitaxel complexed fluorescent carbon nanoparticles: externally NIR light and internally pH sensitive-mediated release of paclitaxel with bio-imaging." Journal of materials chemistry. B vol. 3,28 (2015): 5833-5841. doi: https://doi.org/10.1039/c5tb00779h
Sharker SM, Kim SM, Kim SH, In I, Lee H, Park SY. Target delivery of β-cyclodextrin/paclitaxel complexed fluorescent carbon nanoparticles: externally NIR light and internally pH sensitive-mediated release of paclitaxel with bio-imaging. J Mater Chem B. 2015 Jul 28;3(28):5833-5841. doi: 10.1039/c5tb00779h. Epub 2015 Jun 22. PMID: 32262580.
Copy Download .nbib Format: NLM
Localization of eigenvector centrality in networks with a cut vertex.

Physical review. E

Sharkey KJ.
PMID: 30780242
Phys Rev E. 2019 Jan;99(1):012315. doi: 10.1103/PhysRevE.99.012315.

We show that eigenvector centrality exhibits localization phenomena on networks that can be easily partitioned by the removal of a vertex cut set, the most extreme example being networks with a cut vertex. Three distinct types of localization are...

Cite
Sharkey KJ. Localization of eigenvector centrality in networks with a cut vertex. Phys Rev E. 2019;99(1):012315doi: 10.1103/PhysRevE.99.012315.
Sharkey, K. J. (2019). Localization of eigenvector centrality in networks with a cut vertex. Physical review. E, 99(1), 012315. https://doi.org/10.1103/PhysRevE.99.012315
Sharkey, Kieran J. "Localization of eigenvector centrality in networks with a cut vertex." Physical review. E vol. 99,1 (2019): 012315. doi: https://doi.org/10.1103/PhysRevE.99.012315
Sharkey KJ. Localization of eigenvector centrality in networks with a cut vertex. Phys Rev E. 2019 Jan;99(1):012315. doi: 10.1103/PhysRevE.99.012315. PMID: 30780242.
Copy Download .nbib Format: NLM
Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Bodet-Milin C, Faivre-Chauvet A, Carlier T, Ansquer C, Rauscher A, Frampas E, Toulgoat F, Masson D, Bourgeois M, Cerato E, Rohmer V, Couturier O, Drui D, Goldenberg DM, Sharkey RM, Barbet J, Kraeber-Bodere F.
PMID: 33547213
J Nucl Med. 2021 Sep 01;62(9):1221-1227. doi: 10.2967/jnumed.120.252791. Epub 2021 Feb 05.

Pretargeting parameters for the use of anti-carcinoembryonic antigen (CEA) bispecific monoclonal antibody TF2 and the

Cite
Bodet-Milin C, Faivre-Chauvet A, Carlier T, et al. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study. J Nucl Med. 2021;62(9):1221-1227doi: 10.2967/jnumed.120.252791.
Bodet-Milin, C., Faivre-Chauvet, A., Carlier, T., Ansquer, C., Rauscher, A., Frampas, E., Toulgoat, F., Masson, D., Bourgeois, M., Cerato, E., Rohmer, V., Couturier, O., Drui, D., Goldenberg, D. M., Sharkey, R. M., Barbet, J., & Kraeber-Bodere, F. (2021). Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(9), 1221-1227. https://doi.org/10.2967/jnumed.120.252791
Bodet-Milin, Caroline, et al. "Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 62,9 (2021): 1221-1227. doi: https://doi.org/10.2967/jnumed.120.252791
Bodet-Milin C, Faivre-Chauvet A, Carlier T, Ansquer C, Rauscher A, Frampas E, Toulgoat F, Masson D, Bourgeois M, Cerato E, Rohmer V, Couturier O, Drui D, Goldenberg DM, Sharkey RM, Barbet J, Kraeber-Bodere F. Anti-CEA Pretargeted Immuno-PET Shows Higher Sensitivity Than DOPA PET/CT in Detecting Relapsing Metastatic Medullary Thyroid Carcinoma: Post Hoc Analysis of the iPET-MTC Study. J Nucl Med. 2021 Sep 01;62(9):1221-1227. doi: 10.2967/jnumed.120.252791. Epub 2021 Feb 05. PMID: 33547213.
Copy Download .nbib Format: NLM
Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study.

Clinical nutrition (Edinburgh, Scotland)

French C, Lal S, Jones D, Sowerbutts AM, Brundrett D, Burch N, Calvert C, Cooper SC, Donnellan C, Forbes A, Gabe S, Lam C, Major G, Mountford CG, Muggridge R, Natarajan B, Neild P, Rogers D, Sharkey L, Thompson B, Wheatley C, Burden S.
PMID: 35007818
Clin Nutr. 2021 Dec 23;41(2):500-507. doi: 10.1016/j.clnu.2021.12.030. Epub 2021 Dec 23.

BACKGROUND & AIMS: Home parenteral nutrition (HPN) is a necessary treatment for patients with chronic, type 3, intestinal failure (IF). HPN often requires lifestyle adaptations, which are likely to affect quality of life (QoL) in both patients and family...

Cite
French C, Lal S, Jones D, et al. Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clin Nutr. 2021;41(2):500-507doi: 10.1016/j.clnu.2021.12.030.
French, C., Lal, S., Jones, D., Sowerbutts, A. M., Brundrett, D., Burch, N., Calvert, C., Cooper, S. C., Donnellan, C., Forbes, A., Gabe, S., Lam, C., Major, G., Mountford, C. G., Muggridge, R., Natarajan, B., Neild, P., Rogers, D., Sharkey, L., Thompson, B., Wheatley, C., & Burden, S. (2021). Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clinical nutrition (Edinburgh, Scotland), 41(2), 500-507. https://doi.org/10.1016/j.clnu.2021.12.030
French, Chloe, et al. "Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study." Clinical nutrition (Edinburgh, Scotland) vol. 41,2 (2021): 500-507. doi: https://doi.org/10.1016/j.clnu.2021.12.030
French C, Lal S, Jones D, Sowerbutts AM, Brundrett D, Burch N, Calvert C, Cooper SC, Donnellan C, Forbes A, Gabe S, Lam C, Major G, Mountford CG, Muggridge R, Natarajan B, Neild P, Rogers D, Sharkey L, Thompson B, Wheatley C, Burden S. Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clin Nutr. 2021 Dec 23;41(2):500-507. doi: 10.1016/j.clnu.2021.12.030. Epub 2021 Dec 23. PMID: 35007818.
Copy Download .nbib Format: NLM
Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study.

Clinical nutrition (Edinburgh, Scotland)

French C, Lal S, Jones D, Sowerbutts AM, Brundrett D, Burch N, Calvert C, Cooper SC, Donnellan C, Forbes A, Gabe S, Lam C, Major G, Mountford CG, Muggridge R, Natarajan B, Neild P, Rogers D, Sharkey L, Thompson B, Wheatley C, Burden S.
PMID: 35007818
Clin Nutr. 2021 Dec 23;41(2):500-507. doi: 10.1016/j.clnu.2021.12.030. Epub 2021 Dec 23.

BACKGROUND & AIMS: Home parenteral nutrition (HPN) is a necessary treatment for patients with chronic, type 3, intestinal failure (IF). HPN often requires lifestyle adaptations, which are likely to affect quality of life (QoL) in both patients and family...

Cite
French C, Lal S, Jones D, et al. Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clin Nutr. 2021;41(2):500-507doi: 10.1016/j.clnu.2021.12.030.
French, C., Lal, S., Jones, D., Sowerbutts, A. M., Brundrett, D., Burch, N., Calvert, C., Cooper, S. C., Donnellan, C., Forbes, A., Gabe, S., Lam, C., Major, G., Mountford, C. G., Muggridge, R., Natarajan, B., Neild, P., Rogers, D., Sharkey, L., Thompson, B., Wheatley, C., & Burden, S. (2021). Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clinical nutrition (Edinburgh, Scotland), 41(2), 500-507. https://doi.org/10.1016/j.clnu.2021.12.030
French, Chloe, et al. "Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study." Clinical nutrition (Edinburgh, Scotland) vol. 41,2 (2021): 500-507. doi: https://doi.org/10.1016/j.clnu.2021.12.030
French C, Lal S, Jones D, Sowerbutts AM, Brundrett D, Burch N, Calvert C, Cooper SC, Donnellan C, Forbes A, Gabe S, Lam C, Major G, Mountford CG, Muggridge R, Natarajan B, Neild P, Rogers D, Sharkey L, Thompson B, Wheatley C, Burden S. Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clin Nutr. 2021 Dec 23;41(2):500-507. doi: 10.1016/j.clnu.2021.12.030. Epub 2021 Dec 23. PMID: 35007818.
Copy Download .nbib Format: NLM
Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study.

Clinical nutrition (Edinburgh, Scotland)

French C, Lal S, Jones D, Sowerbutts AM, Brundrett D, Burch N, Calvert C, Cooper SC, Donnellan C, Forbes A, Gabe S, Lam C, Major G, Mountford CG, Muggridge R, Natarajan B, Neild P, Rogers D, Sharkey L, Thompson B, Wheatley C, Burden S.
PMID: 35007818
Clin Nutr. 2021 Dec 23;41(2):500-507. doi: 10.1016/j.clnu.2021.12.030. Epub 2021 Dec 23.

BACKGROUND & AIMS: Home parenteral nutrition (HPN) is a necessary treatment for patients with chronic, type 3, intestinal failure (IF). HPN often requires lifestyle adaptations, which are likely to affect quality of life (QoL) in both patients and family...

Cite
French C, Lal S, Jones D, et al. Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clin Nutr. 2021;41(2):500-507doi: 10.1016/j.clnu.2021.12.030.
French, C., Lal, S., Jones, D., Sowerbutts, A. M., Brundrett, D., Burch, N., Calvert, C., Cooper, S. C., Donnellan, C., Forbes, A., Gabe, S., Lam, C., Major, G., Mountford, C. G., Muggridge, R., Natarajan, B., Neild, P., Rogers, D., Sharkey, L., Thompson, B., Wheatley, C., & Burden, S. (2021). Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clinical nutrition (Edinburgh, Scotland), 41(2), 500-507. https://doi.org/10.1016/j.clnu.2021.12.030
French, Chloe, et al. "Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study." Clinical nutrition (Edinburgh, Scotland) vol. 41,2 (2021): 500-507. doi: https://doi.org/10.1016/j.clnu.2021.12.030
French C, Lal S, Jones D, Sowerbutts AM, Brundrett D, Burch N, Calvert C, Cooper SC, Donnellan C, Forbes A, Gabe S, Lam C, Major G, Mountford CG, Muggridge R, Natarajan B, Neild P, Rogers D, Sharkey L, Thompson B, Wheatley C, Burden S. Impact of home parenteral nutrition on family members: A national multi-centre cross-sectional study. Clin Nutr. 2021 Dec 23;41(2):500-507. doi: 10.1016/j.clnu.2021.12.030. Epub 2021 Dec 23. PMID: 35007818.
Copy Download .nbib Format: NLM
Approximating Quasi-Stationary Behaviour in Network-Based SIS Dynamics.

Bulletin of mathematical biology

Overton CE, Wilkinson RR, Loyinmi A, Miller JC, Sharkey KJ.
PMID: 34800180
Bull Math Biol. 2021 Nov 20;84(1):4. doi: 10.1007/s11538-021-00964-7.

Deterministic approximations to stochastic Susceptible-Infectious-Susceptible models typically predict a stable endemic steady-state when above threshold. This can be hard to relate to the underlying stochastic dynamics, which has no endemic steady-state but can exhibit approximately stable behaviour. Here, we...

Cite
Overton CE, Wilkinson RR, Loyinmi A, et al. Approximating Quasi-Stationary Behaviour in Network-Based SIS Dynamics. Bull Math Biol. 2021;84(1):4doi: 10.1007/s11538-021-00964-7.
Overton, C. E., Wilkinson, R. R., Loyinmi, A., Miller, J. C., & Sharkey, K. J. (2021). Approximating Quasi-Stationary Behaviour in Network-Based SIS Dynamics. Bulletin of mathematical biology, 84(1), 4. https://doi.org/10.1007/s11538-021-00964-7
Overton, Christopher E, et al. "Approximating Quasi-Stationary Behaviour in Network-Based SIS Dynamics." Bulletin of mathematical biology vol. 84,1 (2021): 4. doi: https://doi.org/10.1007/s11538-021-00964-7
Overton CE, Wilkinson RR, Loyinmi A, Miller JC, Sharkey KJ. Approximating Quasi-Stationary Behaviour in Network-Based SIS Dynamics. Bull Math Biol. 2021 Nov 20;84(1):4. doi: 10.1007/s11538-021-00964-7. PMID: 34800180.
Copy Download .nbib Format: NLM
Antenatal prediction of fetal macrosomia in pregnancies affected by maternal pre-gestational diabetes.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

O'Dwyer V, Russell NM, McDonnell B, Sharkey L, Mulcahy C, Higgins MF.
PMID: 34229553
J Matern Fetal Neonatal Med. 2021 Jul 06;1-5. doi: 10.1080/14767058.2021.1949447. Epub 2021 Jul 06.

AIMS: Higher rates of fetal macrosomia may occur in infants of women with pre-gestational diabetes compared with non-diabetic controls. Antenatal predication of fetal macrosomia remains challenging. Ultrasound over-estimated fetal weight could result in over-classification of fetuses as macrosomic with...

Cite
O'Dwyer V, Russell NM, McDonnell B, et al. Antenatal prediction of fetal macrosomia in pregnancies affected by maternal pre-gestational diabetes. J Matern Fetal Neonatal Med. 2021;1-5doi: 10.1080/14767058.2021.1949447.
O'Dwyer, V., Russell, N. M., McDonnell, B., Sharkey, L., Mulcahy, C., & Higgins, M. F. (2021). Antenatal prediction of fetal macrosomia in pregnancies affected by maternal pre-gestational diabetes. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-5. https://doi.org/10.1080/14767058.2021.1949447
O'Dwyer, V, et al. "Antenatal prediction of fetal macrosomia in pregnancies affected by maternal pre-gestational diabetes." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2021): 1-5. doi: https://doi.org/10.1080/14767058.2021.1949447
O'Dwyer V, Russell NM, McDonnell B, Sharkey L, Mulcahy C, Higgins MF. Antenatal prediction of fetal macrosomia in pregnancies affected by maternal pre-gestational diabetes. J Matern Fetal Neonatal Med. 2021 Jul 06;1-5. doi: 10.1080/14767058.2021.1949447. Epub 2021 Jul 06. PMID: 34229553.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 187 entries